Defining levels of dengue virus serotype-specific neutralizing antibodies induced by a live attenuated tetravalent dengue vaccine (TAK-003)

The four dengue virus serotypes (DENV1-4) infect several hundred million people each year living in tropical and sub-tropical regions. Clinical development of DENV vaccines is difficult because immunity to a single serotype increases risk of severe disease during a second infection with a new seroty...

Descripción completa

Detalles Bibliográficos
Autores principales: White, Laura J., Young, Ellen F., Stoops, Mark J., Henein, Sandra R., Adams, Elizabeth C., Baric, Ralph S., de Silva, Aravinda M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990299/
https://www.ncbi.nlm.nih.gov/pubmed/33711074
http://dx.doi.org/10.1371/journal.pntd.0009258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7990299/
https://www.ncbi.nlm.nih.gov/pubmed/33711074
http://dx.doi.org/10.1371/journal.pntd.0009258

Ejemplares similares